Terminated OBSERVATIONAL NCT05614128

Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP

Sponsor: CSL Behring

Conditions CIDP

Interventions IVIg

Updated 5 times since 2022 Last updated: Jun 2, 2025 Started: Feb 28, 2023 Primary completion: Sep 19, 2024 Completion: Sep 19, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Difficulty with Recruitment, Lack of Funding

Other terminated trials from CSL Behring

See all terminations from CSL Behring

This observational or N/A phase trial investigates CIDP and is currently terminated or withdrawn. CSL Behring leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Jul 2025 — Present [monthly]

Terminated

Status: Recruiting → Terminated
Sep 2024 — Jul 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2023 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Dec 2022 — Jun 2023 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CSL Behring
Vanderbilt University Medical Center

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States